Two Stocks To Ponder On: Westlake Chemical Corporation (NYSE:WLK), American Renal Associates Holdings, Inc (NYSE:ARA)

Westlake Chemical Corporation (NYSE:WLK)

Westlake Chemical Corporation (NYSE:WLK) closed at $90.53 on the last trading session with an increase of 2.19%, whereas, it previously closed at $88.59. The company has a market capitalization of $11.81 Billion. The company traded shares of 209943 on the trading day while its three month average volume stands at 309.05 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Westlake Chemical Corporation (NYSE:WLK) produced diluted EPS of 2.25. The EPS estimate for next year as estimated by analysts is at 3.25 while EPS for next quarter is estimated at 0.65. Earnings per Share growth for this year is reported at -57.3, while the analysts estimated the EPS growth for next year at 3.25% and Earnings growth for next 5 years stands at 7.51% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -8.5%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Westlake Chemical Corporation (NYSE:WLK) is at 40.33 while the forward p/e is at 27.86. The P/S or Price to Sales ratio of Westlake Chemical Corporation (NYSE:WLK) stands at 1.59 and Price to Book or P/B for the most recent quarter stands at 1.94. The Price to Free Cash Flow ratio or P/FCF is reported at 24.77. The quick ratio and the current ratio of Westlake Chemical Corporation (NYSE:WLK) are reported at 2.1 and 2.8 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Westlake Chemical Corporation (NYSE:WLK) stands at 2.1, 4.9 and 5.9 respectively

The trailing twelve month Revenue of Westlake Chemical Corporation (NYSE:WLK) is reported at 7.42 Billion with income of 288 Million. The outstanding shares of Westlake Chemical Corporation (NYSE:WLK) are 127.7 Million. The institutional Ownership of the shares of 28 stands at 0.80%, this figure is decreased -0.05 in the last six months. The insider ownership for the shares of Westlake Chemical Corporation (NYSE:WLK) is ticked at 0.5%, the figure is plummeted -12.39% in the last six months.

Some other important financial aspects to be discussed here for Westlake Chemical Corporation (NYSE:WLK) is the Mean Target Price estimated by the analysts which stands at 80.39. The 52 week high of Westlake Chemical Corporation (NYSE:WLK) is placed at 91.83 and 52 week low is standing at 28.99.

Performance wise the shares of Westlake Chemical Corporation (NYSE:WLK) rose up 6.95% for the week, it also rise 7.67% for the monthly performance, while for the quarter it went down 29.9%. The shares increase 69.66% for the half year and flew up for the Year-To-Date performance. The shares of Westlake Chemical Corporation (NYSE:WLK) grew 31.36% for the yearly performance.

American Renal Associates Holdings, Inc (NYSE:ARA)

American Renal Associates Holdings, Inc (NYSE:ARA) closed at $11.46 on the last trading session with an decrease of -0.09%, whereas, it previously closed at $11.47. The company has a market capitalization of $395.94 Million. The company traded shares of 120846 on the trading day while its three month average volume stands at 141.79 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of American Renal Associates Holdings, Inc (NYSE:ARA) produced diluted EPS of -0.52. The EPS estimate for next year as estimated by analysts is at 0.14 while EPS for next quarter is estimated at 0.09. Earnings per Share growth for this year is reported at 31.1, while the analysts estimated the EPS growth for next year at 0.14% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -26.5%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of American Renal Associates Holdings, Inc (NYSE:ARA) is at 0 while the forward p/e is at 81.86. The P/S or Price to Sales ratio of American Renal Associates Holdings, Inc (NYSE:ARA) stands at 0.49 and Price to Book or P/B for the most recent quarter stands at 0. The Price to Free Cash Flow ratio or P/FCF is reported at 2.58. The quick ratio and the current ratio of American Renal Associates Holdings, Inc (NYSE:ARA) are reported at 1 and 1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for American Renal Associates Holdings, Inc (NYSE:ARA) stands at -1.5, 20.8 and 13.7 respectively

The trailing twelve month Revenue of American Renal Associates Holdings, Inc (NYSE:ARA) is reported at 814.1 Million with income of -16900000. The outstanding shares of American Renal Associates Holdings, Inc (NYSE:ARA) are 33.47 Million. The institutional Ownership of the shares of 82.2 stands at 0.80%, this figure is increased 0.04 in the last six months. The insider ownership for the shares of American Renal Associates Holdings, Inc (NYSE:ARA) is ticked at 0.5%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for American Renal Associates Holdings, Inc (NYSE:ARA) is the Mean Target Price estimated by the analysts which stands at 10. The 52 week high of American Renal Associates Holdings, Inc (NYSE:ARA) is placed at 11.98 and 52 week low is standing at 5.57.

Performance wise the shares of American Renal Associates Holdings, Inc (NYSE:ARA) rose up 0.09% for the week, it also rise 0.35% for the monthly performance, while for the quarter it went up -0.43%. The shares increase 73.64% for the half year and flew up for the Year-To-Date performance. The shares of American Renal Associates Holdings, Inc (NYSE:ARA) grew 19.37% for the yearly performance.